SelSym Biotech is developing innovative therapeutics for addressing critical clinical needs to transform patient care and outcomes in the areas of hemorrhage control, surgical bleeding, and wound healing.
SelSym: Revolutionizing Hemorrhage Control
Like so many innovations, the ideas that launched SelSym Biotech emerged over a few cups of coffee and some furious scribbling on napkins. Those conversations led to a remarkable collaboration between ambitious scientists, engineers, and clinicians – all of whom were driven to address the key unmet clinical needs in trauma and hemorrhage treatment and management. Now more than a decade later, those ideas have become the foundation of SelSym’s Hemostatic Healing Hydrogel technology, which holds tremendous promise in transforming the care of traumatic injury and post-surgical bleeding.